| 引用本文: | 张迅杰,贺美莲,杭宝建,石峰,巩丽萍,张乃斌,咸瑞卿.UHPLC-MS/MS测定人血浆中的阿普斯特浓度及生物等效性研究[J].药学研究,2024,43(1):44-49[点击复制] |
|
| 本文已被:浏览 3231次 下载 3000次 |
 码上扫一扫! |
| UHPLC-MS/MS测定人血浆中的阿普斯特浓度及生物等效性研究 |
| 张迅杰1,贺美莲1,杭宝建1,石峰1,巩丽萍1,张乃斌1,咸瑞卿1,2 |
|
|
| (1.山东省食品药品检验研究院,国家药品监督管理局仿制药研究与评价重点实验室,山东省仿制药一致性评价工程技术研究中心,产业技术基础公共服务平台,山东 济南 250101;2.山东大学药学院,山东 济南 250012) |
|
| 摘要: |
| 目的 采用超高效液相色谱-串联质谱(UHPLC-MS/MS)法,建立了快速、 简单、 灵敏的测定人血浆中阿普斯特浓度的方法并用于阿普斯特人体生物等效性试验研究。方法 采用蛋白沉淀法处理,以阿普斯特-d5作为内标,色谱柱为Phenomenex Kinetex C18柱(2.1 mm×50 mm, 2.6 µm),流动相为0.1%甲酸水-0.1%甲酸乙腈,流速0.45 mL·min-1梯度洗脱,采用电喷雾(ESI) 离子源以正离子方式进行MRM检测,用时3 min。结果 阿普斯特在 2~600 ng·mL-1 (r2=0.997 7)范围内线性关系良好,准确度和精密度均小于15%。空腹和餐后条件下阿普斯特片受试制剂AUC0-t、AUC0-∞和Cmax的90% CI为参比制剂相应参数的80.00 %~125.00 %范围内。结论 受试制剂与参比制剂具有生物等效性。 |
| 关键词: 阿普斯特 超高效液相色谱-串联质谱 生物等效性 人血浆 |
| DOI:10.13506/j.cnki.jpr.2024.01.009 |
| 基金项目:山东省重点研发计划(重大关键技术)-药物一致性评价共性关键技术研究(No.2016ZDJS07A04) |
|
出版日期:2024-01-25
|
|
| Determination of apremilast concentration in human plasma UHPLC-MS/MS and its bioequivalence study |
| ZHANG Xunjie1,HE Meilian1,HANG Baojian1,SHI Feng1,GONG Liping1,ZHANG Naibin1,XIAN Ruiqing1,2 |
| (1.Shandong Institute for Food and Drug Control, Shandong Research Center of Engineer and Technology for Consistency Evaluation of Generic Drugs, National Medical Products Administration( NMPA) Key laboratory for Quality Evaluation of Gelatin Products, Industrial Technology Foundation Public Service Platform,Jinan 250101, China;2.Cheeloo College of Medicine, Shandong University, Jinan 250012, China) |
| Abstract: |
| Objective A UHPLC-MS/MS method was developed for determination of apremilast in human plasma and the bioequivalence study. Methods Plasma sample was treated with methanol for protein precipitation while apremilast-d5 was used as internal standard (IS). Separation was achieved on a Phenomenex Kinetex C18 column (2.1×50 mm, 2.6 μm) by gradient elution at a flow rate of 0.45 mL·min-1, with acetonitrile (containing 0.1% of formic acid ) and water(containing 0.1% formic acid) as mobile phase. Detection was performed using electrospray ionization in positive ion multiple reaction monitoring (MRM) mode for three minutes.Results Calibration curves of apremilast were linear in the concentration range of 2~600 ng·mL-1 (r2=0.997 7), with precisions and accuracies were less than 15%. The 90 % confidence intervals of AUC0-t, AUC0-∞ and Cmax of the test preparations of Apremilast tablets under fasting and postprandial conditions were within the ranges of 80.0 %~125.0 % of the corresponding parameters of the reference preparation.Conclusion The test preparation and reference preparation are bioequivalent. |
| Key words: Apremilast UHPLC-MS/MS Bioequivalence Human plasma |